Superbug antibiotic, scientific advances

A new superbug antibiotic is in the works thanks to scientific advances. Teixobactin is a new antibiotic discovered by medical research scientists in London, and it appears to have the ability to destroy serious infections which have become resistant to all of the current antibiotics available. The superbug antibiotic is not ready to be used on people yet, this could take another year or two, but the discovery shows great promise. Millions of people around the world become infected with one of the superbugs, and these germs do not respond to the antibiotics that are currently used. MRSA and tuberculosis are both becoming more resistant and that leaves physicians with few options when someone develops a serious infection from these germs. The superbug antibiotic Teixobactin has been patented by NovoBiotic Pharmaceuticals.

Science has been working on superbug antibiotics, trying to design a new class of these drugs which will work against resistant strains of bacteria. Until now there have been few promising developments. NovoBiotic Pharmaceuticals co-founder and Northeastern University professor Kim Lewis explained “The discovery of this novel compound challenges long-held scientific beliefs and holds great promise for treating an array of menacing infections.” Many bacteria have developed a resistance to multiple drugs and drug classes, leaving physicians few or no options to fall back on. According to WHO a post-antibiotic era where even routine healthcare and surgical procedures will pose a big threat of superbug infection, could occur during this century if new superbug antibiotics are not quickly developed.